Search Results - "ADAMS, Dianne M"

Refine Results
  1. 1

    Boron-Containing Folate Receptor-Targeted Liposomes as Potential Delivery Agents for Neutron Capture Therapy by Pan, Xing Q, Wang, Huaqing, Shukla, Supriya, Sekido, Masaru, Adams, Dianne M, Tjarks, Werner, Barth, Rolf F, Lee, Robert J

    Published in Bioconjugate chemistry (01-05-2002)
    “…Boron neutron capture therapy (BNCT) depends on the selective delivery of a sufficient number of 10B atoms to tumor cells to sustain a lethal 10B(n,α)7Li…”
    Get full text
    Journal Article
  2. 2

    Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy by Barth, Rolf F, Adams, Dianne M, Soloway, Albert H, Alam, Fazlul, Darby, Michael V

    Published in Bioconjugate chemistry (01-01-1994)
    “…Boron neutron capture therapy (BNCT) is based on the nuclear capture reaction that occurs when boron-10, a stable isotope, is irradiated with low-energy or…”
    Get full text
    Journal Article
  3. 3

    Synthesis and Biological Evaluation of Boron-Containing Polyamines as Potential Agents for Neutron Capture Therapy of Brain Tumors by Zhuo, Jin-Cong, Cai, Jianping, Soloway, Albert H, Barth, Rolf F, Adams, Dianne M, Ji, Weihua, Tjarks, Werner

    Published in Journal of medicinal chemistry (08-04-1999)
    “…New boron-containing spermidine/spermine (SPD/SPM) analogues have been synthesized:  N 5-[4-(2-aminoethyl-o-carboranyl)butyl] and N…”
    Get full text
    Journal Article
  4. 4

    Boronated Epidermal Growth Factor as a Potential Targeting Agent for Boron Neutron Capture Therapy of Brain Tumors by Capala, Jacek, Barth, Rolf F, Bendayan, Moïse, Lauzon, Michel, Adams, Dianne M, Soloway, Albert H, Fenstermaker, Robert A, Carlsson, Jörgen

    Published in Bioconjugate chemistry (01-01-1996)
    “…In order for boron neutron capture therapy (BNCT) to be successful, a large number (∼109) of 10B atoms must be delivered to each cancer cell in order to…”
    Get full text
    Journal Article
  5. 5

    Boron-Containing Polyamines as DNA Targeting Agents for Neutron Capture Therapy of Brain Tumors:  Synthesis and Biological Evaluation by Cai, Jianping, Soloway, Albert H, Barth, Rolf F, Adams, Dianne M, Hariharan, Joya R, Wyzlic, Iwona M, Radcliffe, Krista

    Published in Journal of medicinal chemistry (21-11-1997)
    “…Three series of new boron-containing spermidine/spermine (SPD/SPM) analogues have been synthesized:  N - and N 5-(4-carboranylbutyl) SPD/SPM derivatives…”
    Get full text
    Journal Article
  6. 6

    Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy by Tjarks, Werner, Anisuzzaman, Abul K. M, Liu, Liang, Soloway, Albert H, Barth, Rolf F, Perkins, Douglas J, Adams, Dianne M

    Published in Journal of medicinal chemistry (01-05-1992)
    “…The following boron-containing nucleoside and glucose derivatives have been synthesized as potential boron delivery agents for boron neutron capture therapy…”
    Get full text
    Journal Article
  7. 7

    Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy by Barth, Rolf F, Adams, Dianne M, Soloway, Albert H, Mechetner, Eugene B, Alam, Fazlul, Anisuzzaman, Abul K. M

    Published in Analytical chemistry (Washington) (01-05-1991)
    “…We have developed a safe, simple, and efficient method for boron determination by means of direct-current plasma atomic emission spectroscopy. Tissues were…”
    Get full text
    Journal Article
  8. 8

    Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas by WEILIAN YANG, BARTH, Rolf F, ADAMS, Dianne M, CIESIELSKI, Michael J, FENSTERMAKER, Robert A, SHUKLA, Supriya, TJARKS, Werner, CALIGIURI, Michael A

    Published in Cancer research (Chicago, Ill.) (15-11-2002)
    “…Convection enhanced delivery (CED) is potentially a powerful method to improvethe targeting of macromolecules to the central nervous system by applying a…”
    Get full text
    Journal Article
  9. 9

    Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas by BARTH, Rolf F, WEILIAN YANG, CODERRE, Jeffrey A, ADAMS, Dianne M, ROTARU, Joan H, SHUKLA, Supriya, SEKIDO, Masaru, TJARKS, Werner, FENSTERMAKER, Robert A, CIESIELSKI, Michael, NAWROCKY, Marta M

    Published in Cancer research (Chicago, Ill.) (01-06-2002)
    “…Success of boron neutron capture therapy (BNCT) is dependent on cellular and molecular targeting of sufficient amounts of boron-10 to sustain a lethal (10)B…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors by YANG, W, BARTH, R. F, ADAMS, D. M, SOLOWAY, A. H

    Published in Cancer research (Chicago, Ill.) (01-10-1997)
    “…The gene for epidermal growth factor receptor (EGFR) is amplified or overexpressed in high-grade gliomas but is low or undetectable in normal brain. Recently,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Comparative in vitro evaluation of dequalinium B, a new boron carrier for neutron capture therapy (NCT) by Adams, D M, Ji, W, Barth, R F, Tjarks, W

    Published in Anticancer research (01-09-2000)
    “…A boronated derivative of dequalinium, a delocalized lipophilic cation (DLC), was synthesized as a potential boron carrier for the selective targeting of…”
    Get more information
    Journal Article
  15. 15

    Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent by YANG, Weilian, BARTH, Rolf F, LEVEILLE, Renee, ADAMS, Dianne M, CIESIELSKI, Michael, FENSTERMAKER, Robert A, CAPALA, Jacek

    Published in Journal of neuro-oncology (01-10-2001)
    “…We have previously reported a method for labeling epidermal growth factor (EGF) with technetium-99m and have shown that 99mTc-EGF localized in EGF receptor (R)…”
    Get full text
    Journal Article
  16. 16

    In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas by Tjarks, W, Barth, R F, Rotaru, J H, Adams, D M, Yang, W, Kultyshev, R G, Forrester, J, Barnum, B A, Soloway, A H, Shore, S G

    Published in Anticancer research (01-03-2001)
    “…The in vivo uptake of dodecahydro-closo-dodecaborate derivatives substituted with phosphate- and bisphosphonate groups was evaluated in two different…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Distinct and non-cross-reactive epitopes are recognized on B16 melanoma by LAK cells and anti-B16 monoclonal antibodies by Tzeng, J J, Barth, R F, Johnson, C W, Adams, D M

    “…Two rat anti-B16 melanoma monoclonal antibodies (MoAb), designated IB16-6 and IB16-8, recognize an epitope expressed with high density on the surface of B16…”
    Get more information
    Journal Article
  19. 19

    Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors by Liu, L, Barth, R F, Adams, D M, Soloway, A H, Reisfeld, R A

    Published in Journal of hematotherapy (01-10-1995)
    “…Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when boron-10, a stable isotope, is irradiated with low energy (< or = 0.025…”
    Get more information
    Journal Article
  20. 20

    Limits of sensitivity for the radioimmunodetection of colon cancer by means of a hand held gamma probe by Oredipe, O A, Barth, R F, Tuttle, S E, Adams, D M, Sautins, I, Bucci, D M, Mojzisik, C M, Hinkle, G H, Jewell, S, Steplewski, Z

    “…This study was undertaken to define the limits for the radioimmunodetection of minimal deposits of colorectal cancer cells using a hand held gamma probe. 125I…”
    Get more information
    Journal Article